FAK inhibitor suppresses ovarian cancer growth by inhibiting tumor angiogenesis

Abstract Background Ovarian cancer, the second deadliest gynecological malignancy, necessitates the identification of novel therapeutic targets. Focal adhesion kinase (FAK), a non-receptor tyrosine kinase, has emerged as a promising target for ovarian cancer treatment owing to its diverse regulatory...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jingtian Shen, Zhiru Su, Yihan Shan, Ying Wang, Yi Meng, Zhiling Li, Shuping Miao, Jinyi Zhang, Xiaojian Yan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2026-05-01
Цуврал:	Cancer Cell International
Нөхцлүүд:	Ovarian Cancer Focal Adhesion Kinase (FAK) Anti-angiogenesis Targeted Therapy
Онлайн хандалт:	https://doi.org/10.1186/s12935-026-04325-z
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!